US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 45.170
  • +0.470+1.05%
Trading Nov 29 11:43 ET
2.64BMarket Cap-17521P/E (TTM)

Apogee Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
-19.88M
-14.57M
-10.56M
-16.43M
-9.19M
Net income from continuing operations
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
-111.10%-83.99M
-126.57%-31.74M
---20.84M
---18.89M
---12.53M
---39.79M
---14.01M
Depreciation and amortization
--48K
--36K
--29K
----
----
--0
--0
--0
----
----
Other non cash items
--387K
--280K
--266K
-99.24%87K
----
----
----
----
--11.4M
--563K
Change In working capital
1,290.10%3.73M
-51.84%1.54M
-289.19%-1.31M
-37.80%6.11M
19.36%2.52M
---313K
--3.2M
--694K
--9.82M
--2.11M
-Change in prepaid assets
-95.34%-2.81M
36.82%-1.21M
-3,222.73%-1.46M
-1,587.88%-2.79M
473.94%617K
---1.44M
---1.92M
---44K
---165K
---165K
-Change in payables and accrued expense
505.24%6.81M
-40.14%3.07M
-44.17%412K
-7.14%9.27M
0.18%2.28M
--1.13M
--5.12M
--738K
--9.98M
--2.28M
-Change in other current assets
---46K
----
----
---107K
---107K
--0
----
----
--0
----
-Change in other current liabilities
---229K
---244K
---263K
---270K
---270K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Operating cash flow
-113.90%-42.52M
-101.10%-29.3M
-199.67%-31.64M
-355.11%-74.76M
-223.80%-29.75M
---19.88M
---14.57M
---10.56M
---16.43M
---9.19M
Investing cash flow
Cash flow from continuing investing activities
37.50%-146.38M
-148.71M
-51.74M
-273.91M
-39.69M
-234.22M
0
0
0
0
Net PPE purchase and sale
---751K
---51K
---351K
---167K
---167K
--0
--0
--0
--0
----
Net investment purchase and sale
37.82%-145.63M
---148.66M
---51.39M
---273.74M
---39.53M
---234.22M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
37.50%-146.38M
---148.71M
---51.74M
---273.91M
---39.69M
---234.22M
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-99.88%383K
91.15%-150K
450.52M
87.38%315.39M
-100.13%-213K
317.3M
-1.69M
0
168.32M
158.5M
Net common stock issuance
--0
---541K
--450.5M
--315.39M
97.83%-213K
--315.6M
--0
--0
--0
---9.82M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--168.32M
----
Proceeds from stock option exercised by employees
--383K
--391K
--24K
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-99.88%383K
91.15%-150K
--450.52M
87.38%315.39M
-100.13%-213K
--317.3M
---1.69M
--0
--168.32M
--158.5M
Net cash flow
Beginning cash position
145.94%307.59M
243.69%485.75M
-21.91%118.61M
--151.89M
7,188.77%188.27M
--125.07M
--141.33M
--151.89M
--0
--2.58M
Current changes in cash
-398.29%-188.52M
-995.41%-178.16M
3,577.70%367.14M
-121.91%-33.28M
-146.65%-69.66M
--63.2M
---16.26M
---10.56M
--151.89M
--149.31M
End cash Position
-36.75%119.07M
145.94%307.59M
243.69%485.75M
-21.91%118.61M
-21.91%118.61M
--188.27M
--125.07M
--141.33M
--151.89M
--151.89M
Free cash flow
-117.68%-43.28M
-101.45%-29.35M
-202.99%-31.99M
-356.13%-74.93M
-225.62%-29.92M
---19.88M
---14.57M
---10.56M
---16.43M
---9.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -113.90%-42.52M-101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M-19.88M-14.57M-10.56M-16.43M-9.19M
Net income from continuing operations -135.21%-49.02M-79.06%-33.82M-156.24%-32.09M-111.10%-83.99M-126.57%-31.74M---20.84M---18.89M---12.53M---39.79M---14.01M
Depreciation and amortization --48K--36K--29K----------0--0--0--------
Other non cash items --387K--280K--266K-99.24%87K------------------11.4M--563K
Change In working capital 1,290.10%3.73M-51.84%1.54M-289.19%-1.31M-37.80%6.11M19.36%2.52M---313K--3.2M--694K--9.82M--2.11M
-Change in prepaid assets -95.34%-2.81M36.82%-1.21M-3,222.73%-1.46M-1,587.88%-2.79M473.94%617K---1.44M---1.92M---44K---165K---165K
-Change in payables and accrued expense 505.24%6.81M-40.14%3.07M-44.17%412K-7.14%9.27M0.18%2.28M--1.13M--5.12M--738K--9.98M--2.28M
-Change in other current assets ---46K-----------107K---107K--0----------0----
-Change in other current liabilities ---229K---244K---263K---270K---270K--0--0--0--0----
Cash from discontinued investing activities
Operating cash flow -113.90%-42.52M-101.10%-29.3M-199.67%-31.64M-355.11%-74.76M-223.80%-29.75M---19.88M---14.57M---10.56M---16.43M---9.19M
Investing cash flow
Cash flow from continuing investing activities 37.50%-146.38M-148.71M-51.74M-273.91M-39.69M-234.22M0000
Net PPE purchase and sale ---751K---51K---351K---167K---167K--0--0--0--0----
Net investment purchase and sale 37.82%-145.63M---148.66M---51.39M---273.74M---39.53M---234.22M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 37.50%-146.38M---148.71M---51.74M---273.91M---39.69M---234.22M--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -99.88%383K91.15%-150K450.52M87.38%315.39M-100.13%-213K317.3M-1.69M0168.32M158.5M
Net common stock issuance --0---541K--450.5M--315.39M97.83%-213K--315.6M--0--0--0---9.82M
Net preferred stock issuance --------------0------------------168.32M----
Proceeds from stock option exercised by employees --383K--391K--24K----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow -99.88%383K91.15%-150K--450.52M87.38%315.39M-100.13%-213K--317.3M---1.69M--0--168.32M--158.5M
Net cash flow
Beginning cash position 145.94%307.59M243.69%485.75M-21.91%118.61M--151.89M7,188.77%188.27M--125.07M--141.33M--151.89M--0--2.58M
Current changes in cash -398.29%-188.52M-995.41%-178.16M3,577.70%367.14M-121.91%-33.28M-146.65%-69.66M--63.2M---16.26M---10.56M--151.89M--149.31M
End cash Position -36.75%119.07M145.94%307.59M243.69%485.75M-21.91%118.61M-21.91%118.61M--188.27M--125.07M--141.33M--151.89M--151.89M
Free cash flow -117.68%-43.28M-101.45%-29.35M-202.99%-31.99M-356.13%-74.93M-225.62%-29.92M---19.88M---14.57M---10.56M---16.43M---9.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data